Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?

Authors	M M Hatch, Z Nawas, R Kollipara, S K Tyring
Journal	Journal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 31 Issue 4 Pg. e194 (Apr 2017) ISSN: 1468-3083 [Electronic] England
PMID	27550066 (Publication Type: Case Reports, Letter)
Chemical References	Antiviral Agents
Topics	Antiviral Agents (therapeutic use) Biopsy Hepatitis C (complications, drug therapy) Humans Male Middle Aged Porphyria Cutanea Tarda (complications, diagnosis, drug therapy) Skin (pathology) Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!